Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 62
MetricValuePeriodScopeSource row
Revenue¥842.0bn2023-04-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥289.2bn2023-10-01 → 2023-12-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.13T2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥821.0bn2022-04-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥290.3bn2022-10-01 → 2022-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥8.6bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥7.8bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥3.4bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥8.5bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax−¥1.6bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥2.1bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax−¥101.9bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥848m2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥2.3bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)−¥4.1bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥343m2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥103.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥3.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.5bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income−¥4.4bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥60m2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income−¥3.5bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥3.5bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥1.34Tat 2023-12-31Cons.Assets IFRS
Total assets¥1.41Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.44Tat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥822.0bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥913.9bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥521.3bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥499.9bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥577.8bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥561.5bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥507.7bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥487.4bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥564.9bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥112.4bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥113.9bnat 2023-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥180.6bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥110.0bnat 2022-12-31Cons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥117.7bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥46.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥13.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥16.8bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥33.2bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥37.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥26.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥83.8bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥84.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥33.1bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-8.392023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥0.72023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥-208.892022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-6.62022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥7.062022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-8.392023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥0.692023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-208.892022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-6.62022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥7.042022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio37.8%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio34.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥2.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-10-01 → 2023-12-31−¥631m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥18.9bn
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2023-12-31−¥6.1bn
jpcrp040300-q3r_E00989-000Healthcare Businessreportable segmentsegment profit2023-04-01 → 2023-12-31−¥5.8bn
jpcrp040300-q3r_E00989-000Healthcare Businessreportable segmentsegment profit2023-10-01 → 2023-12-31−¥1.6bn
jpcrp040300-q3r_E00989-000Professional Print Businessreportable segmentsegment profit2023-04-01 → 2023-12-31¥8.8bn
jpcrp040300-q3r_E00989-000Professional Print Businessreportable segmentsegment profit2023-10-01 → 2023-12-31¥5.1bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥29.5bn
—segment totalsegment profit2023-10-01 → 2023-12-31¥14.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-10-01 → 2022-12-31−¥1.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥20.4bn
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥7.3bn
jpcrp040300-q3r_E00989-000Healthcare Businessreportable segmentsegment profit2022-04-01 → 2022-12-31−¥9.0bn
jpcrp040300-q3r_E00989-000Healthcare Businessreportable segmentsegment profit2022-10-01 → 2022-12-31−¥435m
jpcrp040300-q3r_E00989-000Professional Print Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥8.9bn
jpcrp040300-q3r_E00989-000Professional Print Businessreportable segmentsegment profit2022-10-01 → 2022-12-31¥5.4bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥26.7bn
—segment totalsegment profit2022-10-01 → 2022-12-31¥16.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 815
ItemContextValueUnit
Purchase of intangible assets inv cf IFRSCurrentYTDDuration-12801000000JPY
Proceeds from sale of property plant and equipment and intangible assets inv cf IFRSPrior1YTDDuration683000000JPY
Proceeds from sale of property plant and equipment and intangible assets inv cf IFRSCurrentYTDDuration628000000JPY
Payments for acquisition of subsidiaries inv cf IFRSPrior1YTDDuration-662000000JPY
Payments for acquisition of subsidiaries inv cf IFRSCurrentYTDDuration-1409000000JPY
Proceeds from sale of investment securities inv cf IFRSPrior1YTDDuration3777000000JPY
Proceeds from sale of investment securities inv cf IFRSCurrentYTDDuration1541000000JPY
Payments for acquisition of businesses inv cf IFRSPrior1YTDDuration-89000000JPY
Payments for acquisition of businesses inv cf IFRSCurrentYTDDuration-112000000JPY
Other inv cf IFRSPrior1YTDDuration-862000000JPY
Other inv cf IFRSCurrentYTDDuration-1686000000JPY
Net cash provided by used in investing activities IFRSPrior1YTDDuration-25999000000JPY
Net cash provided by used in investing activities IFRSCurrentYTDDuration-33216000000JPY
Net increase decrease in short term borrowings fin cf IFRSPrior1YTDDuration61260000000JPY
Net increase decrease in short term borrowings fin cf IFRSCurrentYTDDuration-57530000000JPY
Proceeds from issuance of bonds and long term borrowings fin cf IFRSPrior1YTDDuration100544000000JPY
Proceeds from issuance of bonds and long term borrowings fin cf IFRSCurrentYTDDuration282000000JPY
Redemption of bonds and repayments of long term borrowings fin cf IFRSPrior1YTDDuration-101822000000JPY
Redemption of bonds and repayments of long term borrowings fin cf IFRSCurrentYTDDuration-10510000000JPY
Repayments of lease obligations fin cf IFRSPrior1YTDDuration-15228000000JPY
Repayments of lease obligations fin cf IFRSCurrentYTDDuration-16000000000JPY
Dividends paid fin cf IFRSPrior1YTDDuration-12156000000JPY
Dividends paid fin cf IFRSCurrentYTDDuration-9000000JPY
Capital contribution from non controlling interests fin cf IFRSPrior1YTDDuration470000000JPY
Capital contribution from non controlling interests fin cf IFRSCurrentYTDDuration-JPY
Proceeds from sales of investments in subsidiaries without loss of control fin cf IFRSPrior1YTDDuration78000000JPY
Proceeds from sales of investments in subsidiaries without loss of control fin cf IFRSCurrentYTDDuration-JPY
Other fin cf IFRSPrior1YTDDuration-0JPY
Other fin cf IFRSCurrentYTDDuration-1000000JPY
Net cash provided by used in financing activities IFRSPrior1YTDDuration33146000000JPY
Net cash provided by used in financing activities IFRSCurrentYTDDuration-83771000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSPrior1YTDDuration1996000000JPY
Effect of exchange rate changes on cash and cash equivalents IFRSCurrentYTDDuration3726000000JPY
Net increase decrease in cash and cash equivalents IFRSPrior1YTDDuration-7647000000JPY
Net increase decrease in cash and cash equivalents IFRSCurrentYTDDuration-66717000000JPY
Cash and cash equivalents IFRSPrior2YearInstant117670000000JPY
Cash and cash equivalents IFRSPrior1YearInstant180574000000JPY
Cash and cash equivalents if different from bs balance IFRSPrior1QuarterInstant110022000000JPY
Cash and cash equivalents if different from bs balance IFRSCurrentQuarterInstant113856000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00989-000DigitalWorkplaceBusinessMember437140000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00989-000ProfessionalPrintBusinessReportableSegmentMember184942000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00989-000HealthcareBusinessReportableSegmentMember96899000000JPY
Sales to external customers IFRSPrior1YTDDuration_jpcrp040300-q3r_E00989-000IndustrialBusinessMember100413000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReportableSegmentsMember819395000000JPY
Sales to external customers IFRSPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember1631000000JPY
Sales to external customers IFRSPrior1YTDDuration_ReconcilingItemsMember-JPY
Sales to external customers IFRSPrior1YTDDuration821027000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q3r_E00989-000DigitalWorkplaceBusinessMember2922000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q3r_E00989-000ProfessionalPrintBusinessReportableSegmentMember109000000JPY
Intersegment sales IFRSPrior1YTDDuration_jpcrp040300-q3r_E00989-000HealthcareBusinessReportableSegmentMember490000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass